Authors:
FELDMAN EJ
SEITER K
DAMON L
LINKER C
RUGO H
RIES C
CASE DC
BEER M
AHMED T
Citation: Ej. Feldman et al., A RANDOMIZED TRIAL OF HIGH-DOSE VS STANDARD-DOSE MITOXANTRONE WITH CYTARABINE IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Leukemia, 11(4), 1997, pp. 485-489
Authors:
DAMON L
RUGO H
WOLF J
BREED C
TRIPATHY D
RIES C
LINKER C
Citation: L. Damon et al., PULMONARY INJURY COMPLICATES THE ADDITION OF PACLITAXEL TO HIGH-DOSE ALKYLATORS AND STEM RESCUE IN PATIENTS WITH BREAST-CANCER, Blood, 90(10), 1997, pp. 4356-4356
Authors:
SCHILLER G
STEWART AK
BALLESTER O
NOGA S
RUGO H
FREYTES C
STADTMAUER E
KOGUT N
TARANFOLO S
STIFF P
PINEIRO L
DALTON W
HO A
VESCIO R
BENYUNES M
JACOBS C
DIPERSIO J
ANDERSON K
BERENSON J
Citation: G. Schiller et al., A PHASE-III STUDY EVALUATING CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA - ENGRAFTMENT RESULTS() SELECTED VERSUS UNSELECTED AUTOLOGOUS PERIPHERAL), Blood, 90(10), 1997, pp. 960-960
Citation: H. Rugo et al., QUALITY-OF-LIFE EVALUATION FOLLOWING 4HC PURGED AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) USING THE BUSULFAN ETOPOSIDE REGIMEN FOR ACUTE MYELOID-LEUKEMIA (AML)/, Blood, 90(10), 1997, pp. 1690-1690
Authors:
VESCIO R
STEWART A
BALLESTER O
NOGA S
RUGO H
FREYTES C
STADTMAUER E
KOGUT N
TARANTOLO S
STIFF P
PINERO L
DALTON W
HO A
SCHILLER G
BENYUNES M
JACOBS C
DIPERSIO J
ANDERSON K
BERENSON J
Citation: R. Vescio et al., MYELOMA CELL TUMOR REDUCTION IN PBPC AUTOGRAFTS FOLLOWING CD34 SELECTION - THE RESULTS OF A PHASE-III TRIAL USING THE CEPRATE DEVICE, Blood, 90(10), 1997, pp. 1872-1872
Authors:
VESCIO R
STEWART A
BALLESTER O
NOGA S
RUGO H
FREYTES C
STADTMAUER E
KOGUT N
TARANTOLO S
STIFF P
PINERO L
DALTON W
HO A
SCHILLER G
BENYUNES M
JACOBS C
DIPERSIO J
ANDERSON K
BERENSON J
Citation: R. Vescio et al., INCREASE IN CIRCULATING TUMOR-CELL BURDEN DURING MOBILIZATION CHEMOTHERAPY PREDICTS FOR RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 2515-2515
Authors:
VESCIO R
WU C
RETTIG M
STEWART A
BALLESTER O
NOGA S
RUGO H
FREYTES C
STADTMAUER E
KOGUT N
TARANTOLO S
STIFF P
PINERO L
DALTON W
HO A
SCHILLER G
BENYUNES M
JACOBS C
DIPERSIO J
ANDERSON K
BERENSON J
Citation: R. Vescio et al., THE DETECTION OF KSHV IS INCREASED BY MOBILIZATION CHEMOTHERAPY AND REDUCED IN AUTOGRAFTS BY CD34-SELECTION, Blood, 90(10), 1997, pp. 2516-2516
Authors:
JOHNSTON L
DAMON L
RIES C
RUGO H
LINKER C
Citation: L. Johnston et al., IDARUBICIN, HIGH-DOSE ETOPOSIDE AND HIGH-DOSE ARA-C (IDEA) TREATMENT OF HIGH-RISK ACUTE-LEUKEMIA - A RANDOMIZED STUDY OF SCHEDULE DEPENDENCY OF ETOPOSIDE, Blood, 88(10), 1996, pp. 855-855
Authors:
VESCIO RA
SCHILLER GJ
STEWART AK
ANDERSON KC
DIPERSIO JF
NOGA SJ
BALLESTER OF
RUGO H
FREYTES CO
WU CH
HAN EJ
CAO J
BELSON DJ
BERENSON JR
Citation: Ra. Vescio et al., QUANTITATIVE ASSESSMENT OF MYELOMA PERIPHERAL-BLOOD AND BONE-MARROW TUMOR BURDEN IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION, Blood, 88(10), 1996, pp. 2551-2551
Citation: H. Rugo et al., SINGLE DAY LARGE-VOLUME LEUKAPHERESIS FOLLOWING STANDARD-DOSE CHEMOTHERAPY FOR BREAST-CANCER IS ADEQUATE FOR TRANSPLANTATION, Blood, 86(10), 1995, pp. 1618-1618
Citation: G. Smith et al., DOSE MODIFICATION REDUCES THE INCIDENCE OF HIGH-DOSE ARA-C (HDAC) NEUROTOXICITY IN PATIENTS WITH RENAL-INSUFFICIENCY, Blood, 84(10), 1994, pp. 10000146-10000146
Citation: H. Rugo et al., TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) WITH SUBCUTANEOUS 5-AZACYTIDINE (AZA C), Blood, 84(10), 1994, pp. 10000317-10000317
Authors:
DAMON L
WOLF I
RUGO H
RIES C
TRACEY M
CECCHI G
GOLD E
LINKER C
Citation: L. Damon et al., AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) FOR NON-HOGKINS (NHL) AND HODGKINS (HD) LYMPHOMA USING A THIOTEPA-BASED PREPARATIVE REGIMEN, Blood, 84(10), 1994, pp. 10000706-10000706